Evan Lippman
Corporate Officer/Principal presso ALNYLAM PHARMACEUTICALS, INC.
Posizioni attive di Evan Lippman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/09/2022 | - |
Storia della carriera di Evan Lippman
Precedenti posizioni note di Evan Lippman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AILERON THERAPEUTICS, INC. | Direttore Finanziario/CFO | 08/01/2015 | 31/12/2016 |
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Direttore operativo | - | - |
| Presidente | - | - | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 14/06/2012 | - |
Formazione di Evan Lippman
| Bucknell University | Undergraduate Degree |
| Georgia State University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Evan Lippman
- Esperienza